MoneyWorks4Me

Concord Drugs informs about certificate

20 Jan 2024 Evaluate

Concord Drugs has informed that it enclosed Certificate under Regulation 74 (5) of SEBI (Depositories & Participants) Regulations, 2018 for the quarter ended 31.12.2023.

The above information is a part of company’s filings submitted to BSE.

Peers
Company Name CMP
Sun Pharma. Inds. 1810.00
Dr. Reddys Labs. 1200.10
Cipla 1346.85
Lupin 2029.00
Zydus Lifesciences 1145.25
View more..